Yip P

No ORCID on file · 4 papers in corpus
2015
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.
Lancet (London, England) ·doi:10.1016/s0140-6736(15)61340-x

BackgroundThe Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable compariso…

2012
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lancet (London, England) ·doi:10.1016/s0140-6736(12)61728-0

BackgroundReliable and timely information on the leading causes of death in populations, and how these are changing, is a crucial input into health policy debates. In the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD…

2011
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers.
PloS one ·doi:10.1371/journal.pone.0029533

FDA-cleared ovarian cancer biomarkers are limited to CA-125 and HE4 for monitoring and recurrence and OVA1, a multivariate panel consisting of CA-125 and four additional biomarkers, for referring patients to a specialist. Due to relatively …

2009
Development and preliminary evaluation of a multivariate index assay for ovarian cancer.
PloS one ·doi:10.1371/journal.pone.0004599

BackgroundMost women with a clinical presentation consistent with ovarian cancer have benign conditions. Therefore methods to distinguish women with ovarian cancer from those with benign conditions would be beneficial. We describe the devel…